Connection

IVAN ROSAS to Vascular Endothelial Growth Factor D

This is a "connection" page, showing publications IVAN ROSAS has written about Vascular Endothelial Growth Factor D.
  1. Everolimus for the treatment of lymphangioleiomyomatosis: a phase II study. Eur Respir J. 2015 Sep; 46(3):783-94.
    View in: PubMed
    Score: 0.123
  2. Transforming growth factor-?1 downregulates vascular endothelial growth factor-D expression in human lung fibroblasts via the Jun NH2-terminal kinase signaling pathway. Mol Med. 2014 Mar 20; 20:120-34.
    View in: PubMed
    Score: 0.112
  3. Aberrant SYK Kinase Signaling Is Essential for Tumorigenesis Induced by TSC2 Inactivation. Cancer Res. 2017 03 15; 77(6):1492-1502.
    View in: PubMed
    Score: 0.034
  4. Sirolimus and Autophagy Inhibition in Lymphangioleiomyomatosis: Results of a Phase I Clinical Trial. Chest. 2017 06; 151(6):1302-1310.
    View in: PubMed
    Score: 0.034
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.